Drug · DIN 02453304
RAVICTI
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 3, 2016; first marketed November 3, 2016.
- Drug Identification Number (DIN)
- 02453304
- Company (DIN owner)
- Horizon Therapeutics Ireland DacDun Laoghaire Co. Dublin, Dublin, Ireland
- Schedule
- Prescription
- Dosage form
- Liquid
- Route
- Oral
- Therapeutic class (ATC)
- Glycerol phenylbutyrate A16AX09
- Class
- Human
- Record last updated
- June 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GLYCEROL PHENYLBUTYRATE | 1.1 G | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 18, 2016: NOC 17888New Drug Submission (NDS)